Evaluations using externally sourced data include a study
demonstrating improved clinical measures²,³ and
statistically significant reductions in the number of secondary
care utilisations and costs across various disease areas¹
Clinical
metrics:
The University of Birmingham conducted an evaluation which
demonstrated that patients with poorly controlled diabetes or
cardiovascular disease in the Birmingham OwnHealth programme
significantly improved clinical measures of disease progression
compared to the control group. The study included 676 OwnHealth
participants which were compared with 31,077 control patients from
General Practice Research Database. The clinical metrics improved
more amongst the OwnHealth patients with cardiovascular disease
compared to the control group².
An evaluation of Birmingham
OwnHealth
Service utilisation and
associated costs:
A 12 month retrospective case-control study of the Birmingham
OwnHealth programme using Secondary Uses Service data investigated
the impact of OwnHealth on the number of spells and cost of care.
The evaluation included 4,200 patients enrolled in the OwnHealth
programme and a corresponding control group of 4,200 patient. Data
from the Commissioning Data Sets, which cover in-patient activity,
out-patient appointments and attendance at Accident and Emergency
departments, were used to calculate secondary care activity. The
cost of spells were calculated from the prices listed for
Healthcare Resource Groups. The data demonstrates that
participation in OwnHealth is associated with statistically
significant reductions in the number of spells and costs across
diabetes, coronary heart disease, heart failure, COPD, hypertension
and cardiovascular disease risk.